5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE
Main Authors: | Y. Saunthararajah, P.G. Woost, U. Friedrich, W.H.O. Clausen, J.W. Jacobberger, H. Lau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000928244.12444.62 |
Similar Items
-
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
by: Robert Molokie, et al.
Published: (2017-09-01) -
P524: PHARMACODYNAMICALLY DEFINED METRONOMIC DOSING OF DECITABINE AND VENETOCLAX IN ACUTE MYELOID LEUKEMIA
by: Kateryna Fedorov, et al.
Published: (2023-08-01) -
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
by: Karahoca Metin, et al.
Published: (2013-02-01) -
Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
by: Shin D, et al.
Published: (2017-01-01) -
A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
by: Jung JA, et al.
Published: (2015-03-01)